Status:
COMPLETED
Bilirubin Levels to Diagnose Appendicitis and Predict Appendiceal Perforation
Lead Sponsor:
Nepalese Army Institute of Health Sciences
Conditions:
Acute Appendicitis
Appendicitis Perforated
Eligibility:
All Genders
5+ years
Brief Summary
The goal of this study is to learn if serum bilirubin levels can aid in the diagnosis of acute appendicitis and predict appendiceal perforation
Detailed Description
The study aims to assess hyperbilirubinemia: serum direct, indirect and total bilirubin to enhance the diagnostic accuracy of acute appendicitis. Also it aims to analyze different patient variables su...
Eligibility Criteria
Inclusion
- Patients of age group above 5 years with acute appendicitis undergoing appendectomy with written informed consent.
Exclusion
- Patients with appendicular lump.
- Patients with acute and chronic liver diseases like acute hepatitis, hemolytic disease, Gilbert's syndrome, Dubin-Johnson syndrome, alcoholic liver disease.
- Acquired or Congenital Biliary Disease.
- History of Hepatotoxic drugs.
Key Trial Info
Start Date :
July 16 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 12 2025
Estimated Enrollment :
98 Patients enrolled
Trial Details
Trial ID
NCT06956638
Start Date
July 16 2022
End Date
March 12 2025
Last Update
May 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shree Birendra Hospital
Kathmandu, Bagmati, Nepal, 44620